PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • VAD - Market size and forecast 2018-2023 • TAH - Market size and forecast 2018-2023 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Clinical trials for the development of TAHs • Focus on development of non-blood-contacting VADs • Strategic acquisitions PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • Abiomed Inc. • Medtronic • ReliantHeart Inc. • SynCardia Systems LLC PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global medical devices market Exhibit 02: Segments of global medical devices market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Product - Market share 2018-2023 (%) Exhibit 18: Comparison by product Exhibit 19: VAD - Market size and forecast 2018-2023 ($ millions) Exhibit 20: VAD - Year-over-year growth 2019-2023 (%) Exhibit 21: TAH - Market size and forecast 2018-2023 ($ millions) Exhibit 22: TAH - Year-over-year growth 2019-2023 (%) Exhibit 23: Market opportunity by product Exhibit 24: Customer landscape Exhibit 25: Market share by geography 2018-2023 (%) Exhibit 26: Geographic comparison Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 28: North America - Year-over-year growth 2019-2023 (%) Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 30: Europe - Year-over-year growth 2019-2023 (%) Exhibit 31: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Asia - Year-over-year growth 2019-2023 (%) Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 34: ROW - Year-over-year growth 2019-2023 (%) Exhibit 35: Key leading countries Exhibit 36: Market opportunity Exhibit 37: Impact of drivers and challenges Exhibit 38: Vendor landscape Exhibit 39: Landscape disruption Exhibit 40: Vendors covered Exhibit 41: Vendor classification Exhibit 42: Market positioning of vendors Exhibit 43: Abbott - Vendor overview Exhibit 44: Abbott - Business segments Exhibit 45: Abbott - Organizational developments Exhibit 46: Abbott - Geographic focus Exhibit 47: Abbott - Segment focus Exhibit 48: Abbott - Key offerings Exhibit 49: Abbott - Key customers Exhibit 50: Abiomed Inc. - Vendor overview Exhibit 51: Abiomed Inc. - Product segments Exhibit 52: Abiomed Inc. - Organizational developments Exhibit 53: Abiomed Inc. - Segment focus Exhibit 54: Abiomed Inc. - Key offerings Exhibit 55: Abiomed Inc. - Key customers Exhibit 56: Medtronic - Vendor overview Exhibit 57: Medtronic - Business segments Exhibit 58: Medtronic - Organizational developments Exhibit 59: Medtronic - Geographic focus Exhibit 60: Medtronic - Segment focus Exhibit 61: Medtronic - Key offerings Exhibit 62: Medtronic - Key customers Exhibit 63: ReliantHeart Inc. - Vendor overview Exhibit 64: ReliantHeart Inc. - Product segments Exhibit 65: ReliantHeart Inc. - Organizational developments Exhibit 66: ReliantHeart Inc. - Key offerings Exhibit 67: ReliantHeart Inc. - Key customers Exhibit 68: SynCardia Systems LLC - Vendor overview Exhibit 69: SynCardia Systems LLC - Product segments Exhibit 70: SynCardia Systems LLC - Organizational developments Exhibit 71: SynCardia Systems LLC - Key offerings Exhibit 72: SynCardia Systems LLC - Key customers Exhibit 73: Validation techniques employed for market sizing Exhibit 74: Definition of market positioning of vendors

Abbott Abiomed Inc. Medtronic ReliantHeart Inc. SynCardia Systems LLC